Press Releases

IRVINE, Calif., Oct. 31, 2019 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (NASDAQ: CYRXW) ("Cryoport" or the "Company"), the world's leading temperature-controlled logistics company dedicated to the life sciences industry, today announced that the Company will report financial results for the third quarter ended September 30, 2019 on

IRVINE, Calif., Oct. 31, 2019 /PRNewswire/ -- Xponential Fitness, the largest curator of boutique fitness brands in the world, today announced that Goldman Sachs has recognized Chief Executive Officer, Anthony Geisler, as one of the 100 Most Intriguing Entrepreneurs of 2019.

BAUDETTE, Minn., Oct. 31, 2019 /PRNewswire/ -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that its partner Pharmaceutics International Inc. (Pii) has received FDA approval of a Prior Approval Supplement for Bretylium Tosylate Injection, USP 500mg/10ml (50mg/ml).  ANI plans to launch this currently unavail

Note: All references to dollar values refer to Canadian dollars unless otherwise stated. TORONTO, Oct. 31, 2019 /PRNewswire/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX:

TEL-AVIV, Israel, Oct. 31, 2019 /PRNewswire/ -- The pharmaceutical company Panaxia Israel, the largest manufacturer and distributor of pharmaceutical cannabis in Israel, announced today, that the audit of the regulatory body of the EU which was conducted at the plant in the past weeks, was successfully completed, and subject t

SEATTLE, Oct. 31, 2019 /PRNewswire/ -- RareCyte announces an addition to the RarePlex® Staining Kit product line, enabling customers to evaluate HER2 and ER expression on circulating tumor cells (CTCs) in their own laboratory. HER2 and ER are biomarkers that direct treatment recommendations for invasive breast cancer, and liquid biopsy offers a blood-based

AUGUSTA, Maine, Oct. 31, 2019 /PRNewswire/ -- Three national nonprofits have petitioned the Federal Trade Commission (FTC) to investigate the Maine Board of Dental Practice for antitrust violations. According to the petition,

SOUTH SAN FRANCISCO, Calif., Oct. 31, 2019 /PRNewswire/ -- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis, today announced that company scientists and research collaborators will present data highlighting Pliant's lead product candidate PLN-74809 at The Liver Meetin

CARLSBAD, Calif., Oct. 31, 2019 /PRNewswire/ -- Thermo Fisher Scientific will host a series of customer presentations during its corporate workshops featuring the latest clinical research data on emerging biomarkers in cancer at the Association for Molecular Pathology (AMP) 2019 annual meeting on Nov. 6. The workshops will highlight det

LOUISVILLE, Ky., Oct. 31, 2019 /PRNewswire/ -- Landmark Recovery, a premier